Organizations

Pfizer

Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them - WSJ

Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them

By: Elizabeth Koh
Source: The Wall Street Journal
Date of Publication: January 4th, 2021
Companies mass producing shots for Pfizer, Moderna and AstraZeneca are racing to find staff: ‘We are truly in unprecedented territory’
J&J enrolls about 45,000 participants for late-stage Covid vaccine trial

J&J enrolls about 45,000 participants for late-stage Covid vaccine trial

By: Reuters
Source: CNBC
Date of Publication: December 18th, 2020
Johnson & Johnson said it has enrolled about 45,000 participants for the first late-stage trial of its Covid-19 single-dose vaccine candidate.
Pfizer, U.S. Reach Deal to Boost Covid-19 Vaccine Supply

Pfizer, U.S. Reach Deal to Boost Covid-19 Vaccine Supply

By: Peter Loftus, Rebecca Ballhaus and Matt Grossman
Source: The Wall Street Journal
Date of Publication: December 23rd, 2020
Company will provide 100 million more doses to bolster campaign under way in U.S.
FDA Finds Moderna Covid-19 Vaccine Highly Effective

FDA Finds Moderna Covid-19 Vaccine Highly Effective

By: Thomas M. Burton and Peter Loftus
Source: The Wall Street Journal
Date of Publication: December 15th, 2020
Second major U.S. coronavirus vaccine could possibly be shipped by this weekend.
FDA chief says agency will quickly approve Pfizer's Covid vaccine for emergency use

FDA chief says agency will quickly approve Pfizer’s Covid vaccine for emergency use

By: Noah Higgins-Dunn and Will Feuer
Source: CNBC
Date of Publication: December 11th, 2020
FDA Commissioner Stephen Hahn tweeted Friday that the agency “is finalizing the necessary documents to ensure that patients and providers have the information that they need to make informed decisions.”
Pfizer building

FDA Says Pfizer-BioNTech Vaccine Is Safe, Effective

By: Thomas M. Burton and Jared S. Hopkins
Source: The Wall Street Journal
Date of Publication: December 8th, 2020
The Food and Drug Administration said the first Covid-19 vaccine being considered for U.S. distribution “met the prescribed success criteria” in a clinical study, paving the way for the agency to green-light distribution as early as this weekend.
First batch of 6.4 million vaccine doses could go out in mid-December - The Washington Post

First 6.4 million doses of Pfizer’s coronavirus vaccine could go out in mid-December

By: Lena H. Sun
Source: The Washington Post
Date of Publication: November 24th, 2020
The federal government plans to send 6.4 million doses of pharmaceutical giant Pfizer’s coronavirus vaccine to communities across the United States within 24 hours of regulatory clearance, with the expectation that shots will be administered quickly to front-line health-care workers, the top priority group, officials said Tuesday.
How two companies sprinted ahead in extraordinary race for a COVID vaccine

How two companies sprinted ahead in extraordinary race for a COVID vaccine

By: Michael Erman, Julie Steenhuysen
Source: Reuters
Date of Publication: November 17th, 2020
Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission: “He basically said, ‘Your mandate is to get this vaccine made. And if you need resources, you come and you ask for them, and you’re going to get them’,”chief viral vaccine scientist Philip Dormitzer told Reuters.
Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states

Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states

Source: Reuters
Date of Publication: November 16th, 2020
Pfizer Inc PFE.N has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements.
BioNTech hopes COVID-19 vaccine will immunize for at least a year

BioNTech hopes COVID-19 vaccine will immunize for at least a year

By: Ludwig Burger, Patricia Weiss
Source: Reuters
Date of Publication: November 9th, 2020
BioNTech's BNTX.O co-founder and chief executive said he was optimistic that the protective effect of its experimental COVID-19 vaccine, co-developed with Pfizer PFE.N, would last for at least a year.